PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.330
-0.040 (-1.19%)
At close: Sep 26, 2025, 4:00 PM EDT
3.335
+0.005 (0.15%)
After-hours: Sep 26, 2025, 4:10 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $52.21 million as of September 26, 2025. Its market cap has increased by 123.07% in one year.
Market Cap
52.21M
Enterprise Value
31.42M
1-Year Change
123.07%
Ranking
Category
Stock Price
$3.33
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $52.21M, a decrease of -36.67%. That is a compound annual growth rate of -8.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 52.21M | 152.42% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 649.96B |
| Johnson & Johnson | 429.79B |
| AbbVie | 390.71B |
| UnitedHealth Group | 315.14B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |